FindTrial
Sign In

System Construction of Precious Diagnosis and Evaluation for Pulmonary Arterial Hpyertension

System Construction of Precious Diagnosis and Evaluation for Pulmonary Arterial Hpyertension

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16009406
Enrollment
Unknown
Registered
2016-10-14
Start date
2016-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary arterial hypertension

Interventions

Gold Standard:
Index test:

Sponsors

Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Group 1 Pulmonary arterial hypertension

Exclusion criteria

Exclusion criteria: Group 2 Pulmonary hypertension Group 3 Pulmonary hypertension Group 4 Pulmonary hypertension Group 5 Pulmonary hypertension

Design outcomes

Primary

MeasureTime frame
clinical worsening events;right heart catherization;cardiopulmonary exerise testing;six-minute walking distance;stresss-echocardiography;CTPA;CMR;biomarker;—

Secondary

MeasureTime frame
Nitrite;Bilirubin;high-density lipoprotein cholesterol;8-Isoprostane F2a;8-Isoprostane F2a;Uric acid;growth differentiation Factor-15;C-reactive protein;D-dimer;von Willebtand Factor;ET-1;Troponin;NT-proBNP;SNP genotype;—

Countries

China

Contacts

Public ContactLiu jin-ming

Shanghai Pulmonary Hospital

jinmingliu2007@163.com+86 13818181063

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026